Selecta Biosciences Q2 EPS $0.00, Sales $19.66M Beat $6.24M Estimate

Selecta Biosciences (NASDAQ:SELB) reported quarterly sales of $19.66 million which beat the analyst consensus estimate of $6.24 million by 215.11 percent.

Selecta Biosciences (NASDAQ:SELB) reported quarterly sales of $19.66 million which beat the analyst consensus estimate of $6.24 million by 215.11 percent.

Total
0
Shares
Related Posts